CS
Jan Weber

Jan Weber

mail jan.weberinvalid-email-name@invalid-email-domainuochb.cas.cz
phone +420 220 183 420
Group leader
Virology
Jan Weber Group
All publications

Latest publications

Antiviral Activity of 7-Substituted 7-Deazapurine Ribonucleosides, Monophosphate Prodrugs, and Triphoshates against Emerging RNA Viruses
N. Milisavljevič E. Konkoľová J. Kozák J. Hodek L. Veselovská V. Sýkorová K. Čížek R. Pohl L. Eyer P. Svoboda D. Růžek J. Weber R. Nencka E. Bouřa M. Hocek
ACS Infectious Diseases 2021: Early View
Go to the publication arrow
Structural characterization of the interaction between the C-terminal domain of the influenza polymerase PA subunit and an optimized small peptide inhibitor
J. Hejdánek K. Radilová P. Pachl J. Hodek A. Machara J. Weber P. Řezáčová J. Konvalinka M. Kožíšek
Antiviral Research 185: 104971 (2021)
Go to the publication arrow
Unraveling the anti-influenza effect of flavonoids: Experimental validation of luteolin and its congeners as potent influenza endonuclease inhibitors
V. Zima K. Radilová M. Kožíšek C. B. Albinana E. Karlukova J. Brynda J. Fanfrlík M. Flieger J. Hodek J. Weber P. Majer J. Konvalinka A. Machara
European Journal of Medicinal Chemistry 208: 112754 (2020)
Go to the publication arrow
Hepatitis B Core Protein Is Post-Translationally Modified through K29-Linked Ubiquitination
H. Langerová B. Lubyová A. Zábranský M. Hubálek K. Glendová L. Aillot J. Hodek D. Strunin V. Janovec I. Hirsch J. Weber
Cells 9 (12): 2547 (2020)
Go to the publication arrow